Chemical Industries Failing to Meet Paris Agreement Goals
In spite of making progress on climate risks, the chemical industry is still failing to accomplish the goals outlined by the Paris Agreement, says a new report by CDP.
Catalyst for Change analyses 22 of the biggest global chemical companies with a aggregate market capitalization of $650 billion and culpable for a quarter of all emissions of the sector at 276 million metric tons of CO2 emissions per year, including AkzoNobel, DuPont, BASF and The Dow Chemical Company. The report reveals rapid process innovations will be required in order for chemical companies to have any chance of aligning with the below 2-degree goal set out by the Paris agreement.
The chemical sector is responsible for an eighth of global industrial CO2 emissions and plays a key role in the world economy, with 95 percent of all manufactured products relying on chemicals. Despite the industry’s ability to innovate on low carbon, it will struggle to fully decarbonize if it doesn’t make rapid and significant changes to its own highly polluting processes.
“As both a large energy user itself and a crucial part of other industrial supply chains, the chemicals industry is an important, but often overlooked, sector when it comes to environmental impact. Today’s analysis shows it’s moving in the right direction across several climate metrics with encouraging signs on annual emissions and R&D, but it needs to go further and faster to invest in the technologies that will deliver efficiency and emissions improvements,” said Paul Simpson, CEO of CDP.
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
FDA Warning Letters Put GMP Back in Focus
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
Recommend Reading
-
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
关于进一步规范化学品信息发布、加强全球管制目录宣导的公告 Announcement on Further Standardizing the Release of Chemical Information and Strengthening Public Awareness of Global Control Lists
-
Silver Nitrate: Medical Uses, Photography History, and Staining Properties
-
This Week's Styrene Market Fluctuates and Rises (9.15-9.19) in China
-
This Week's Activated Carbon Prices Remain Stable (9.15-9.19) in China
-
This week, the market price of epichlorohydrin showed a significant downward trend in China (9.15-9.19)
-
This Week, the Focus is on Consolidation in China's Titanium Dioxide Market (9.15-9.19)